Jane Street Group, LLC Night Hawk Biosciences, Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.26 - $0.51 $7,925 - $15,546
30,483 New
30,483 $13,000
Q4 2022

Feb 14, 2023
BUY
$0.77 - $1.62 $12,191 - $25,649
15,833 New
15,833 $12,000
Q2 2022

Aug 16, 2022
SELL
$1.65 - $3.13 $29,333 - $55,645
-17,778 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$2.1 - $3.54 $12,929 - $21,795
-6,157 Reduced 25.72%
17,778 $54,000
Q4 2021

Feb 15, 2022
BUY
$3.04 - $6.01 $72,762 - $143,849
23,935 New
23,935 $72,000

Others Institutions Holding NHWK

# of Institutions
5
Shares Held
48.5K
Call Options Held
0
Put Options Held
0
View Full List

About NightHawk Biosciences, Inc.

NHWK Quotes by TradingView
  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email